Lansoprazole Capsule, Delayed Release
Product Images NDC 80425-0174

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 80425-0174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

A line graph showing the mean severity of day heartburn over time from the start of treatment for evaluable patients. The severity scale ranges from 0 (none) to 3 (severe). It compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, across approximately 60 days. Both lansoprazole groups show a reduction in heartburn severity compared to placebo.*

FDA Label Image

Fig 2 (Fig 2)

A line graph showing mean severity of night heartburn over days from start of treatment for evaluable patients. The y-axis represents mean severity from 0 (none) to 3 (severe). The x-axis shows days from -5 to 60. Three lines compare placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity decreasing over time for both Lansoprazole doses compared to placebo.*

FDA Label Image

Lansoprazole Dr 30mg Cap #30 (Lansoprazole Dr 30mg Cap Qty 30 Ndc 80425 0174)

Label for Lansoprazole DR 30 mg delayed-release capsules, package size 30, labeled by Advanced Rx Pharmacy of Tennessee, LLC. The label includes product and lot numbers, expiration date, storage instructions at 20°-25°C (68°-77°F), and a caution about federal law prohibiting drug transfer. Barcode and proprietary logo are visible.*

FDA Label Image

Logo (Logo)

Lansoprazole DR 30 mg delayed-release capsules carton labeling from Advanced Rx Pharmacy of Tennessee, LLC. The front panel displays the product name, dosage strength, dosage form, and route of administration. The packaging is white with purple and gray accents and includes the labeler information and a warning about the prescription-only status.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole, the active ingredient in Lansoprazole DR 30 mg delayed-release capsules by Advanced Rx Pharmacy of Tennessee, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.